Literature DB >> 9176159

A synthetic peptide derived from glycine-gated Cl- channel induces transepithelial Cl- and fluid secretion.

D P Wallace1, J M Tomich, T Iwamoto, K Henderson, J J Grantham, L P Sullivan.   

Abstract

M2GlyR is a synthetic 23-amino acid peptide that mimics the second membrane-spanning region of the alpha-subunit of the postsynaptic glycine receptor. This peptide has been shown to form an anion-selective channel in phospholipid bilayers. We have investigated the possibility that the peptide may incorporate into the apical membrane of secretory epithelia and induce the secretion of Cl- and water. We improved the solubility of this peptide by adding four lysine residues to the carboxy terminus, C-K4-M2GlyR, and assayed its channel-forming activity using a subculture of Madin-Darby canine kidney (MDCK) cells. The addition of 100 microM C-K4-M2GlyR to the apical surface of MDCK monolayers significantly increased short-circuit current (Ise), hyperpolarized transepithelial potential difference, and induced fluid secretion. The increase in Ise was inhibited by 100 microM bumetanide and by Cl- channel inhibitors. The effectiveness of the channel blockers followed the sequence niflumic acid > or = 5-nitro-2-(3-phenylpropylamino)benzoate > diphenylamine-2-carboxylate (DPC) > glibenclamide. The effect of the peptide was not inhibited by 4.4'-diisothiocyanostilbene-2-2'-disulfonic acid. Removing Cl from the bathing solutions also inhibited the effect of the peptide. The Cl- efflux pathway induced by C-K4-M2GlyR differs from the native pathway activated by the adenosine 3',5'-cyclic monophosphate (cAMP) agonist, forskolin. First, intracellular cAMP levels were unaffected. Second, the concentration of DPC required to inhibit the effect of the peptide was much lower than that needed to block the forskolin response (100 microM vs. 3 mM). These results support the hypothesis that the synthetic peptide C-K4-M2GlyR can from Cl -selective channels in the apical membrane of secretory epithelial cells and can induce sustained transepithelial secretion of Cl- and fluid.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176159     DOI: 10.1152/ajpcell.1997.272.5.C1672

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Expression of an artificial Cl- channel in microperfused renal proximal tubules.

Authors:  N Matsumoto; S Tsuruoka; T Iwamoto; J M Tomich; K Ito; M Imai; M Suzuki
Journal:  J Membr Biol       Date:  2003-06-01       Impact factor: 1.843

2.  Structural and biophysical properties of a synthetic channel-forming peptide: designing a clinically relevant anion selective pore.

Authors:  U Bukovnik; J Gao; G A Cook; L P Shank; M B Seabra; B D Schultz; T Iwamoto; J Chen; J M Tomich
Journal:  Biochim Biophys Acta       Date:  2011-07-31

3.  Redesigning channel-forming peptides: amino acid substitutions that enhance rates of supramolecular self-assembly and raise ion transport activity.

Authors:  Lalida P Shank; James R Broughman; Wade Takeguchi; Gabriel Cook; Ashley S Robbins; Lindsey Hahn; Gary Radke; Takeo Iwamoto; Bruce D Schultz; John M Tomich
Journal:  Biophys J       Date:  2005-12-30       Impact factor: 4.033

4.  Conformation and environment of channel-forming peptides: a simulation study.

Authors:  Jennifer M Johnston; Gabriel A Cook; John M Tomich; Mark S P Sansom
Journal:  Biophys J       Date:  2005-12-30       Impact factor: 4.033

Review 5.  Development of synthetic membrane transporters for anions.

Authors:  Anthony P Davis; David N Sheppard; Bradley D Smith
Journal:  Chem Soc Rev       Date:  2006-10-23       Impact factor: 54.564

6.  Immunity to a self-derived, channel-forming peptide in the respiratory tract.

Authors:  Frederik W van Ginkel; Takeo Iwamoto; Bruce D Schultz; John M Tomich
Journal:  Clin Vaccine Immunol       Date:  2007-12-19

7.  Effect of diaminopropionic acid (Dap) on the biophysical properties of a modified synthetic channel-forming peptide.

Authors:  Urska Bukovnik; Monica Sala-Rabanal; Simonne Francis; Shawnalea J Frazier; Bruce D Schultz; Colin G Nichols; John M Tomich
Journal:  Mol Pharm       Date:  2013-09-23       Impact factor: 4.939

8.  Epithelial barrier modulation by a channel forming peptide.

Authors:  Suma Somasekharan; Robert Brandt; Takeo Iwamoto; John M Tomich; Bruce D Schultz
Journal:  J Membr Biol       Date:  2008-03       Impact factor: 1.843

9.  Aqueous solubilization of transmembrane peptide sequences with retention of membrane insertion and function.

Authors:  J M Tomich; D Wallace; K Henderson; K E Mitchell; G Radke; R Brandt; C A Ambler; A J Scott; J Grantham; L Sullivan; T Iwamoto
Journal:  Biophys J       Date:  1998-01       Impact factor: 4.033

10.  NC-1059: a channel-forming peptide that modulates drug delivery across in vitro corneal epithelium.

Authors:  Jesica Martin; Pradeep Malreddy; Takeo Iwamoto; Lisa C Freeman; Harriet J Davidson; John M Tomich; Bruce D Schultz
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-21       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.